User profiles for Bernd Jahrsdörfer

Bernd Jahrsdoerfer

Professor für Klinische Pharmakologie
Verified email at blutspende.de
Cited by 9581

Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

…, S Britsch, A Krug, B Jahrsdörfer… - The Journal of …, 2002 - journals.aai.org
The Toll-like receptor (TLR) 9 is critical for the recognition of immunostimulatory CpG motifs
but may cooperate with other TLRs. We analyzed TLR1–10 mRNA expression by using …

[PDF][PDF] SARS-CoV-2 variants B. 1.351 and P. 1 escape from neutralizing antibodies

…, MS Winkler, S Schulz, HM Jäck, B Jahrsdörfer… - Cell, 2021 - cell.com
The global spread of SARS-CoV-2/COVID-19 is devastating health systems and economies
worldwide. Recombinant or vaccine-induced neutralizing antibodies are used to combat the …

Identification of CpG oligonucleotide sequences with high induction of IFN‐α/β in plasmacytoid dendritic cells

…, V Hornung, B Jahrsdörfer… - European journal of …, 2001 - Wiley Online Library
The immature plasmacytoid dendritic cell (PDC) is identical with the principal type I IFN‐producing
cell upon viral infection. Oligodeoxynucleotides which contain unmethylated CpG …

Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients

…, F Halleck, U Weber, F Szelinski, B Jahrsdörfer… - Science …, 2021 - science.org
Patients with kidney failure are at increased risk of SARS-CoV-2 infection, making effective
vaccinations a critical need. It is not known how well mRNA vaccines induce B and plasma …

Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients

…, H Schrezenmeier, B Jahrsdörfer… - The Journal of …, 2021 - Am Soc Clin Investig
Novel mRNA-based vaccines have been proven to be powerful tools in combating the global
pandemic caused by SARS-CoV-2, with BNT162b2 (trade name: Comirnaty) efficiently …

Interleukin 21–induced granzyme B–expressing B cells infiltrate tumors and regulate T cells

…, P Möller, H Schrezenmeier, B Jahrsdörfer - Cancer research, 2013 - AACR
The pathogenic impact of tumor-infiltrating B cells is unresolved at present, however, some
studies suggest that they may have immune regulatory potential. Here, we report that the …

Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS …

…, W Liu, BH Hahn, A Beil, J Kroschel, B Jahrsdörfer… - …, 2022 - thelancet.com
Background Heterologous COVID-19 vaccination regimens combining vector- and mRNA-based
vaccines are already administered, but data on solicited adverse reactions, …

Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model

…, A Schlamp, J Seiderer, B Jahrsdörfer… - The Journal of …, 2002 - journals.aai.org
The immune system of vertebrates is able to detect bacterial DNA based on the presence of
unmethylated CpG motifs. We examined the therapeutic potential of oligodeoxynucleotides …

Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion

B Jahrsdörfer, A Vollmer, SE Blackwell… - Blood, The Journal …, 2010 - ashpublications.org
Human plasmacytoid dendritic cells (pDCs) are crucially involved in the modulation of adaptive
T-cell responses in the course of neoplastic, viral, and autoimmune disorders. In several …

Robust and durable serological response following pediatric SARS-CoV-2 infection

…, B Müller, C Ludwig, B Jahrsdörfer… - Nature …, 2022 - nature.com
The quality and persistence of children’s humoral immune response following SARS-CoV-2
infection remains largely unknown but will be crucial to guide pediatric SARS-CoV-2 …